摘要
目的:探讨咳嗽变异性哮喘的特异性免疫治疗效果。方法:对92例咳嗽变异性哮喘(CVA)患者根据变应原种类不同进行特异性免疫治疗,并根据CVA评分结果进行分析。结果:92例患者中有效78例,占84.8%,无效9例,占9.8%,复发5例,占5.4%。有效的78例患者免疫治疗时间持续3年以上,无效及复发的患者免疫治疗时间少于2~4年。结论:咳嗽变异性哮喘的特异性免疫治疗效果理想,其特异性免疫治疗维持时间是治疗CVA的关键。
@@@@[ABSTRCT]Objective:To study treatment effects of Specific immunotherapy for cough variant asthma. Methods:92 cases of cough variant asthma patients were treated with Specific immunotherapy according to the type of allergen,then evaluate the effects according to the CVA score. Results:78 patients received significant effects in 92 cases, occupying 84.8%, treatment effects of 9 patients are ineffective in 92 cases, occupying 9.8%,5 patients relapsed, occupying 5.4%, The continual treat time of 78 patients received significant effects is over 3 years, the continual treat time of those ineffective or relapsed patients is less 2~4 years. Conclusion:The treatment effect of Specific immunotherapy for cough variant asthma is significant, but the continual treat time is the most important for CVA .
出处
《中国医药导刊》
2013年第4期599-600,共2页
Chinese Journal of Medicinal Guide